146 related articles for article (PubMed ID: 16547074)
21. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity.
Pearce RE; McIntyre CJ; Madan A; Sanzgiri U; Draper AJ; Bullock PL; Cook DC; Burton LA; Latham J; Nevins C; Parkinson A
Arch Biochem Biophys; 1996 Jul; 331(2):145-69. PubMed ID: 8660694
[TBL] [Abstract][Full Text] [Related]
22. Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2.
Popovich DG; Kitts DD
Can J Physiol Pharmacol; 2004 Mar; 82(3):183-90. PubMed ID: 15052284
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes.
Kim KA; Lee JS; Park HJ; Kim JW; Kim CJ; Shim IS; Kim NJ; Han SM; Lim S
Life Sci; 2004 Apr; 74(22):2769-79. PubMed ID: 15043991
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.
McGinnity DF; Berry AJ; Kenny JR; Grime K; Riley RJ
Drug Metab Dispos; 2006 Aug; 34(8):1291-300. PubMed ID: 16679385
[TBL] [Abstract][Full Text] [Related]
25. Degradation of ginsenosides in humans after oral administration.
Tawab MA; Bahr U; Karas M; Wurglics M; Schubert-Zsilavecz M
Drug Metab Dispos; 2003 Aug; 31(8):1065-71. PubMed ID: 12867496
[TBL] [Abstract][Full Text] [Related]
26. 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide.
Oh GS; Pae HO; Choi BM; Seo EA; Kim DH; Shin MK; Kim JD; Kim JB; Chung HT
Cancer Lett; 2004 Mar; 205(1):23-9. PubMed ID: 15036657
[TBL] [Abstract][Full Text] [Related]
27. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.
Arbus C; Benyamina A; Llorca PM; Baylé F; Bromet N; Massiere F; Garay RP; Hameg A
Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033
[TBL] [Abstract][Full Text] [Related]
28. Stereoselective formation and metabolism of 20(S)-protopanaxadiol ocotillol type epimers in vivo and in vitro.
Wang W; Wang L; Wu X; Xu L; Meng Q; Liu W
Chirality; 2015 Feb; 27(2):170-6. PubMed ID: 25422175
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
[TBL] [Abstract][Full Text] [Related]
30. Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity.
Henderson GL; Harkey MR; Gershwin ME; Hackman RM; Stern JS; Stresser DM
Life Sci; 1999; 65(15):PL209-14. PubMed ID: 10574228
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 CYP716A53v2 catalyzes the formation of protopanaxatriol from protopanaxadiol during ginsenoside biosynthesis in Panax ginseng.
Han JY; Hwang HS; Choi SW; Kim HJ; Choi YE
Plant Cell Physiol; 2012 Sep; 53(9):1535-45. PubMed ID: 22875608
[TBL] [Abstract][Full Text] [Related]
32. Screening of Drug Metabolizing Enzymes for the Ginsenoside Compound K In Vitro: An Efficient Anti-Cancer Substance Originating from Panax Ginseng.
Xiao J; Chen D; Lin XX; Peng SF; Xiao MF; Huang WH; Wang YC; Peng JB; Zhang W; Ouyang DS; Chen Y
PLoS One; 2016; 11(2):e0147183. PubMed ID: 26845774
[TBL] [Abstract][Full Text] [Related]
33. Fungal sensitivity to and enzymatic deglycosylation of ginsenosides.
Zhao X; Gao J; Song C; Fang Q; Wang N; Zhao T; Liu D; Zhou Y
Phytochemistry; 2012 Jun; 78():65-71. PubMed ID: 22449289
[TBL] [Abstract][Full Text] [Related]
34. Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 May; 141():94-103. PubMed ID: 24486455
[TBL] [Abstract][Full Text] [Related]
35. Deglycosylated ginsenosides are more potent inducers of CYP1A1, CYP1A2 and CYP3A4 expression in HepG2 cells than glycosylated ginsenosides.
Hao M; Ba Q; Yin J; Li J; Zhao Y; Wang H
Drug Metab Pharmacokinet; 2011; 26(2):201-5. PubMed ID: 21178302
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of 20(S)-protopanaxadiol on cytochrome P450: Potential of its pharmacokinetic interactions in vivo.
Lee SG; Cho KH; Nguyen TT; Vo DK; Chae YJ; Maeng HJ
Biomed Pharmacother; 2022 Sep; 153():113514. PubMed ID: 36076601
[TBL] [Abstract][Full Text] [Related]
37. Combinatorial metabolism notably affects human systemic exposure to ginsenosides from orally administered extract of Panax notoginseng roots (Sanqi).
Hu Z; Yang J; Cheng C; Huang Y; Du F; Wang F; Niu W; Xu F; Jiang R; Gao X; Li C
Drug Metab Dispos; 2013 Jul; 41(7):1457-69. PubMed ID: 23649704
[TBL] [Abstract][Full Text] [Related]
38. Different pharmacokinetics of the two structurally similar dammarane sapogenins, protopanaxatriol and protopanaxadiol, in rats.
Kong LT; Wang Q; Xiao BX; Liao YH; He XX; Ye LH; Liu XM; Chang Q
Fitoterapia; 2013 Apr; 86():48-53. PubMed ID: 23391424
[TBL] [Abstract][Full Text] [Related]
39. Molecular profiling of ginsenoside metabolites to identify estrogen receptor alpha activity.
Kikegawa M; Nakajima A; Yu J; Asai M; Uesawa Y; Sone H
Gene; 2022 Mar; 813():146108. PubMed ID: 34929341
[TBL] [Abstract][Full Text] [Related]
40.
Jang SN; Park SY; Lee H; Jeong H; Jeon JH; Song IS; Kwon MJ; Liu KH
Xenobiotica; 2021 Oct; 51(10):1087-1094. PubMed ID: 34338601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
